Stroke Trial, Recruiting NCT07147660 Sponsor: University of South-Eastern Norway Condition: Stroke
Back to Stroke

Stroke Trial, Recruiting

NCT07147660
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • Adults between the ages of 20 and 85 who have a visual field defect (a loss of part of their vision) caused by a stroke
  • People whose Norwegian Class 1 driving licence was revoked no more than five years ago
  • People who speak a Scandinavian language (such as Norwegian, Swedish, or Danish)
  • People who are able to sign a written consent form to participate
  • People who are motivated and willing to take part in study activities over a total period of 20 to 28 weeks
  • People who own a personal computer, which is needed for digital check-ins and online vision training exercises
  • People who are able to travel to Oslo for data collection visits

Who may not be able to join:

  • People who have a condition called strabismus (where the eyes do not point in the same direction) and/or visual neglect (a condition where a person is unaware of things on one side of their vision)
  • People who have an eye disease or other health condition that would prevent them from meeting the medical requirements for a Norwegian Class 1 driving licence
  • People who have cognitive impairment, dementia, a severe psychiatric diagnosis, or who are otherwise unable to sign a written consent form

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 6 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Helle Falkenberg, Professor, University of South-Eastern Norway

Phone: +47 31 00 92 05

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
University of South-Eastern Norway
Registry
ClinicalTrials.gov
Start date
28 March 2025
Est. completion
1 December 2027

Where this trial is recruiting

🇳🇴 Norway

Primary endpoints

Visual Field measured with Saccadic Reaction Time in ms

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 6 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov